Join

Compare · CNMD vs INMD

CNMD vs INMD

Side-by-side comparison of CONMED Corporation (CNMD) and InMode Ltd. (INMD): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CNMD and INMD operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
  • CNMD is the larger of the two at $1.16B, about 1.3x INMD ($912.4M).
  • Over the past year, CNMD is down 24.5% and INMD is up 1.0% - INMD leads by 25.5 points.
  • CNMD has been more active in the news (2 items in the past 4 weeks vs 1 for INMD).
  • INMD has more recent analyst coverage (20 ratings vs 14 for CNMD).
PerformanceCNMD-24.48%INMD+1.02%
2025-04-28+0.00%2026-04-24
MetricCNMDINMD
Company
CONMED Corporation
InMode Ltd.
Price
$38.41+2.52%
$14.40+0.14%
Market cap
$1.16B
$912.4M
1M return
+3.74%
+4.80%
1Y return
-24.48%
+1.02%
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
NYSE
NASDAQ
IPO
1987
2019
News (4w)
2
1
Recent ratings
14
20
CNMD

CONMED Corporation

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

INMD

InMode Ltd.

InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. InMode Ltd. offers its products directly in United States, Canada, United Kingdom, Spain, India, Australia, and France, as well as through distributors in 47 countries. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.